phone icon (917) 310-3371 Explore MAT Treatment Menu
close menu
Nao Medical Logo

Suboxone covered by Medicaid in NYC

Find Suboxone and buprenorphine treatment with Medicaid, Medicare, commercial insurance, or self-pay review across NYC and Long Island.

Many major insurance plans are accepted for addiction medicine visits, including Medicaid, Medicare, Medicare Advantage, Healthfirst, MetroPlus, Fidelis, UnitedHealthcare, United Healthcare Community Plan, EmblemHealth, Aetna, Cigna, Blue Cross Blue Shield, and many commercial plans. Self-pay visits are also available. Coverage for the visit, urine drug screening, and medication copays varies by plan, so benefit verification still matters.

NYC Health identifies buprenorphine as a medication for opioid use disorder and notes that Medicaid, Medicare, and most health plans pay for it. Individual benefits still need verification before care is finalized.

Nao Medical clinic visit
Nao Medical clinic interior
Nao Medical patient care
Coverage should be clear before treatment starts The goal is a practical plan: confirm benefits, understand visit and pharmacy pieces, then schedule the right local or virtual follow-up.

What Medicaid patients should know

Insurance can support treatment, but the details matter. A strong Suboxone plan checks the visit, testing, pharmacy, medication, and follow-up pieces together.

Medicaid plan review

Coverage can involve the medical visit, urine drug screening, pharmacy benefits, medication copays, and prior authorization. Verifying benefits before the plan starts prevents avoidable surprises.

Common Medicaid managed-care pathways

Patients often ask about Healthfirst, MetroPlus, Fidelis, UnitedHealthcare Community Plan, and other New York Medicaid managed-care plans. Acceptance and benefits should be checked for the individual patient.

Medication plus follow-up

Suboxone care is not only the prescription. The visit should also cover timing, safety, monitoring, follow-up cadence, and what to do if withdrawal or cravings change.

Telemedicine plus local backup

Virtual care can reduce friction for the right patient, while nearby locations remain important for exams, testing, injection options, or in-person follow-up.

Official treatment context

Medication treatment for opioid use disorder is evidence-based care. Patients can review public guidance from NYC Health, FDA, and New York OASAS.

Local MAT access across NYC and Long Island

Related MAT options

Medicaid and Suboxone questions

NYC Health states that Medicaid, Medicare, and most health plans pay for buprenorphine. Coverage details still depend on the specific Medicaid managed-care plan, visit type, pharmacy benefits, urine drug screening, and prior authorization rules.
Many Medicaid managed-care plans are accepted for addiction medicine visits. The care team should verify benefits before the plan moves forward because coverage can differ by plan and service.
Telemedicine may be available when clinically appropriate and when the payer requirements can be met. Some patients still need an in-person visit, lab work, or local follow-up.
Coverage can vary, and self-pay options may be available when a patient chooses that route. For patients using a self-pay path for Suboxone-based care, current self-pay pricing is $350 for the initial visit including UDS, $200 for follow-up visits including UDS, and $100 for a short bridge visit when clinically appropriate.

200,000+ 5-star reviews

What patients say about Nao Medical

Verified Patient
(4.9)

The visit was private, clear, and focused on what I needed to do next.

Verified Patient
(4.9)

They helped me understand medication timing and follow-up without making me feel judged.

Verified Patient
(4.9)

Insurance questions were handled before the plan moved forward.

Verified Patient
(4.9)

The team explained telemedicine and in-person follow-up in a way that made sense.

Verified Patient
(4.9)

I left with clearer next steps and a realistic appointment plan.

Verified Patient
(4.9)

The clinic made a difficult appointment feel organized and respectful.